Avelumab is under clinical development by Merck and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...

Axitinib is under clinical development by Pfizer and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...

I had the privilege of talking with Dr. Anbukkani Subbian, a leading Gynecological Oncologist based in Coimbatore, to discuss ...

Immune checkpoint inhibitors are the superheroes of cancer therapy. | Immune checkpoint inhibitors are the superheroes of ...

Pembrolizumab plus chemoradiotherapy improved survival in patients with previously untreated, high-risk locally advanced ...

Patients with previously untreated, high-risk locally advanced cervical cancer experienced improved survival when treated ...

Skin cancer is the most common form of cancer nationwide each year, according to the Centers for Disease Control and Prevention.

Gov. Kathy Hochul is reminding everyone to get checked for skin cancer after she had a procedure to remove basal cell carcinoma.

The abstract by Baek et al entitled “Prognostic Value of Routine Blood Markers in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)” (JCO Global ... Sidney Kimmel Cancer Center, Philadelphia ...

Pembrolizumab combined with chemoradiotherapy followed by pembrolizumab monotherapy significantly improved survival compared ...